Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
MedPage Today) -- The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer...
MedPage Today) -- The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer...